Literature DB >> 24277184

Continuous measurements of ATP secretion in vivo.

J B Smith1, S E Burke, A M Lefer, A Freilich.   

Abstract

Blood was withdrawn continuously from femoral veins of anesthetized rabbits at a rate of 0.07 ml/min. Sodium citrate was pumped into the blood to prevent coagulation, and luciferin-luciferase reagent was added to permit the continuous detection of extracellular ATP. Subsequently, the red blood cells were lysed and the platelet count was recorded continuously. Injection of platelet activating factor or collagen into rabbit ear veins caused an almost immediate but short-lived increase in extracellular ATP with a simultaneous but more prolonged decrease in the platelet count. Although both the endoperoxide analog 9,11-azo-PGH2 and ADP also decreased the platelet count, little extracellular ATP was detected after the azo-PGH2 and none after ADP. These studies demonstrate that those agents that cause platelet secretion from rabbit platelets in vitro also cause secretion in vivo. The method described should be useful in evaluating the capacity of antithrombotic drugs to modify platelet secretion in vivo.

Entities:  

Year:  1984        PMID: 24277184     DOI: 10.1023/A:1016382710359

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

Review 1.  Secretable storage pools in platelets.

Authors:  H Holmsen; H J Weiss
Journal:  Annu Rev Med       Date:  1979       Impact factor: 13.739

Review 2.  Use of the Technicon Autocounter for animal platelet counting and for continuous monitoring of circulating platelet number.

Authors:  I B Holmes; F Freuler
Journal:  Pharmacol Ther B       Date:  1979

3.  Interrelations of platelet aggregation and secretion.

Authors:  I F Charo; R D Feinman; T C Detwiler
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

4.  The platelet defect associated with albinism.

Authors:  R M Hardisty; D C Mills
Journal:  Ann N Y Acad Sci       Date:  1972-10-27       Impact factor: 5.691

5.  The measurement of intravascular aggregation by continuous platelet counting.

Authors:  G M Smith; F Freuler
Journal:  Bibl Anat       Date:  1973

6.  Direct measurement of platelet secretion in whole blood.

Authors:  C M Ingerman; J B Smith; M J Silver
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

7.  Platelet factor 4 levels in patients with coronary artery disease.

Authors:  G L White; A A Marouf
Journal:  J Lab Clin Med       Date:  1981-03

8.  Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.

Authors:  L M McManus; D J Hanahan; C A Demopoulos; R N Pinckard
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

9.  Elevated beta-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy.

Authors:  F E Preston; J D Ward; B H Marcola; N R Porter; W R Timperley; B C O'Malley
Journal:  Lancet       Date:  1978-02-04       Impact factor: 79.321

10.  Plasma beta-thromboglobulin in diabetes mellitus.

Authors:  I W Campbell; J Dawes; D M Fraser; D S Pepper; B F Clarke; L J Duncan; J D Cash
Journal:  Diabetes       Date:  1977-12       Impact factor: 9.461

View more
  1 in total

1.  Ischemia aggravating effects of platelet-activating factor in acute myocardial ischemia.

Authors:  I Leprán; A M Lefer
Journal:  Basic Res Cardiol       Date:  1985 Mar-Apr       Impact factor: 17.165

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.